Product Categories
Country: | China |
---|---|
Tel: | |
Mobile: | 15092135101 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Olmesartan intermediate impurity IV | C13H22N2O3 | 1092980-84-1 | Details |
Methyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | C17H18N2O3S | 923942-34-1 | Details |
Dehydro Nifedipine N-Oxide | C17H16N2O7 | 88434-69-9 | Details |
Febuxostat Impurity 8 | C16H17NO4S | 144060-62-8 | Details |
5-(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydrop yridine-3-carboxylic acid | C16H16N2O6 | 74936-71-3 | Details |
Ethyl4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate | C12H18N2O4 | 144689-94-1 | Details |
Nifedipine | C11H15NO4 | 17438-14-1 | Details |
ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE | C18H21NO4S | 161798-03-4 | Details |
vildagliptin Impurity F | C17H24N2O3 | 1789703-36-1 | Details |
Febuxostat Descyano Impurity | C15H17NO3S | 1206550-99-3 | Details |
methyl (Z)-2-(2-nitrosobenzylidene)-3-oxobutanoate | C12H11NO5 | 39562-27-1 | Details |
4-Hydroxyisophthalonitrile | C8H4N2O | 34133-58-9 | Details |
Ethyl2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | C18H20N2O3S | 160844-75-7 | Details |
Dehydro Olmesartan | C24H24N6O2 | 172875-98-8 | Details |
4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid | C10H16N2O3 | 144690-04-0 | Details |
Norfloxacin Impurity 6 | C21H15N5O6 | 126192-88-9 | Details |
diethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5- dicarboxylate | C19H22N2O6 | 21829-26-5 | Details |
Olmesartan | C24H26N6O3 | 144689-24-7 | Details |
Nifedipine Impurity 21 | C19H18N4O6 | 80742-13-8 | Details |
Olmesartan Impurity 58 | C12H22N2O2 | 2190488-06-1 | Details |
2-[3-(AMinocarbonyl)-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid | C16H18N2O4S | 1239233-86-3 | Details |
2-[3-Carboxy-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid | C16H17NO5S | 1239233-87-4 | Details |
FeBuxostat Impurity 18 | C12H9NO4S | 1312815-35-2 | Details |
Nifedipine Impurity E | C16H17N3O5 | 114709-68-1 | Details |
ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate | C15H13NO5S | 2073891-59-3 | Details |
DehydroNifedipine | C17H16N2O6 | 67035-22-7 | Details |
Ethyl4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate | C12H20N2O3 | 144689-93-0 | Details |
Vildagliptin carboxy acid metabolite | C17H26N2O4 | 565453-40-9 | Details |
OlMesartan interMediate iMpurity II | C11H16N2O3 | 144690-07-3 | Details |
Febuxostat Impurity 6 | C18H22N2O4S | 1271738-74-9 | Details |
2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid | C12H8N2O3S | 407582-48-3 | Details |
vildagliptin Impurity R | C7H8Cl2N2O | 1803168-09-3 | Details |
m-Nifedipine | C17H18N2O6 | 21881-77-6 | Details |
OlmesartanEPImpurityB | C24H24N6O2 | 849206-43-5 | Details |
Olmesartan Medoxomil Impurity U | C26H30N6O3 | 144689-23-6 | Details |
Febuxostat Impurity 14 | C15H16N2OS | 1335202-60-2 | Details |
Dehydronitrosonifedipine | C17H16N2O5 | 50428-14-3 | Details |
4-CHLOROPHTHALIC ACID MONOSODIUM SALT | C8H6ClNaO4 | 56047-23-5 | Details |
4-(1-Methylethenyl)-2-propyl-1H-Imidazole-5-carboxylic acidethylester | C12H18N2O2 | 157356-73-5 | Details |
5-(5-(ethoxycarbonyl)-4-methylthiazol-2-yl)-2-isobutoxybenzoic acid | C18H21NO5S | 2095166-41-7 | Details |
5-Thiazolecarboxylic acid, 2-[3-(ethoxycarbonyl)-4-(2-methylpropoxy)phenyl]-4-methyl- | C18H21NO5S | 2476465-11-7 | Details |
4-(1-Hydroxy-1-methylpropyl)-2-propyl-1H-Imidazole-5-carboxylic acidethylester | C13H22N2O3 | 172875-53-5 | Details |
Febuxostat Impurity 7 | C16H18N2O4S | 1350352-70-3 | Details |
3-ethyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine- 3,5-dicarboxylate | C18H20N2O6 | 53055-15-5 | Details |
Nifedipine Impurity 7 | C19H18N4O6 | 80742-11-6 | Details |
Febuxostat Impurity 130 | C20H25NO5S | 1643131-93-4 | Details |
Nonivamide | C17H27NO3 | 2444-46-4 | Details |
2-(2-Hydroxyphenyl)-4-methyl-5-thiazolecarboxylic acid ethyl ester | C13H13NO3S | 118485-48-6 | Details |
Olmesartan Impurity 9 | C10H14N2O2 | 849206-42-4 | Details |
Trityl olmesartan | C48H44N6O6 | 144690-92-6 | Details |
dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarb oxylate | C17H18N2O6 | 21829-09-4 | Details |
N-DesMethyl DiphenhydraMine Hydrochloride | C16H20ClNO | 53499-40-4 | Details |
Nitrendipine EP Impurity C | C19H22N2O6 | 21829-28-7 | Details |
Olmesartan MedoxomiI Impurity C | 87956-26-2 | Details |
vildagliptin Impurity E | C17H25N3O2 | 1789703-37-2 | Details |
Febuxostat Impurity 32 HCl | C12H11NO3S | 1267681-15-1 | Details |
Cerium silicide | CeSi2 | 12014-85-6 | Details |
Product Total: Product Page: | ||||
1 2 |